EDITORIAL
Published on 17 May 2022
Editorial: Development and Potential Mechanisms of Low Molecular Weight Drugs for Cancer Immunotherapy
doi 10.3389/fimmu.2022.920442
- 929 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Development and Potential Mechanisms of Low Molecular Weight Drugs for Cancer Immunotherapy
Development and Potential Mechanisms of Low Molecular Weight Drugs for Cancer Immunotherapy
25k
Total downloads
100k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 02 May 2022
Small Molecule Agents Targeting PD-1 Checkpoint Pathway for Cancer Immunotherapy: Mechanisms of Action and Other Considerations for Their Advanced Development
doi 10.3389/fimmu.2022.752065
- 12,935 views
- 37 citations
REVIEW
Published on 12 Jan 2022
Toripalimab: the First Domestic Anti-Tumor PD-1 Antibody in China
doi 10.3389/fimmu.2021.730666
- 32,909 views
- 59 citations
ORIGINAL RESEARCH
Published on 25 Nov 2021
Pseudomonas aeruginosa PcrV Enhances the Nitric Oxide-Mediated Tumoricidal Activity of Tumor-Associated Macrophages via a TLR4/PI3K/AKT/mTOR-Glycolysis-Nitric Oxide Circuit
doi 10.3389/fonc.2021.736882
- 2,287 views
- 8 citations
REVIEW
Published on 12 Nov 2021
Vitamin C, From Supplement to Treatment: A Re-Emerging Adjunct for Cancer Immunotherapy?
doi 10.3389/fimmu.2021.765906
- 7,448 views
- 13 citations
CASE REPORT
Published on 26 Oct 2021
Axitinib Reverses Resistance to Anti-Programmed Cell Death-1 Therapy in a Patient With Renal Cell Carcinoma
doi 10.3389/fimmu.2021.728750
- 2,092 views
- 5 citations
ORIGINAL RESEARCH
Published on 19 Aug 2021
Tumor Temporal Proteome Profiling Reveals the Immunological Triple Offensive Induced by Synthetic Anti-Cancer Salmonella
doi 10.3389/fimmu.2021.712936
- 2,784 views
- 8 citations
REVIEW
Published on 06 Jul 2021
A Promising Anticancer Agent Dimethoxycurcumin: Aspects of Pharmacokinetics, Efficacy, Mechanism, and Nanoformulation for Drug Delivery
doi 10.3389/fphar.2021.665387
- 2,788 views
- 11 citations
ORIGINAL RESEARCH
Published on 14 Jun 2021
The Novel Curcumin Derivative 1g Induces Mitochondrial and ER-Stress-Dependent Apoptosis in Colon Cancer Cells by Induction of ROS Production
doi 10.3389/fonc.2021.644197
- 3,151 views
- 17 citations
ORIGINAL RESEARCH
Published on 14 May 2021
A Small Molecule Antagonist of PD-1/PD-L1 Interactions Acts as an Immune Checkpoint Inhibitor for NSCLC and Melanoma Immunotherapy
doi 10.3389/fimmu.2021.654463
- 17,905 views
- 32 citations
ORIGINAL RESEARCH
Published on 22 Apr 2021
Perillaldehyde Inhibition of cGAS Reduces dsDNA-Induced Interferon Response
doi 10.3389/fimmu.2021.655637
- 4,945 views
- 25 citations
ORIGINAL RESEARCH
Published on 30 Mar 2021
A Local and Low-Dose Chemotherapy/Autophagy-Enhancing Regimen Treatment Markedly Inhibited the Growth of Established Solid Tumors Through a Systemic Antitumor Immune Response
doi 10.3389/fonc.2021.658254
- 3,038 views
- 10 citations
Published in
Frontiers in Immunology
- Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Frontiers in Pharmacology
- 4.4 impact factor
- 7.8 citescore
Impact
- 100kTopic views
- 73kArticle views
- 25kArticle downloads